Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Healthcare Bioconvergence Market Size, Share & Industry Trends Analysis Report By Application (Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics), By Regional Outlook and Forecast, 2022 - 2028

Published Date : 31-Dec-2022

Pages: 142

Formats: PDF

The Global Healthcare Bioconvergence Market size is expected to reach $169.9 billion by 2028, rising at a market growth of 7.0% CAGR during the forecast period.

Bioconvergence is an all-encompassing strategy that addresses many biotech chain links, including bioprinting, biomimicry, omics, and diagnostics. By combining biology with several engineering disciplines like nanotechnology, physics, computer science, advanced genetic engineering, artificial intelligence, material science, and electronics, this process is known as bio convergence.

Healthcare Bioconvergence Market - Global Opportunities and Trends Analysis Report 2018-2028

Bioconvergence is a sector of the healthcare and life science research industries that stresses the interdependence of engineering, technology, and computerized systems. The idea behind bioconvergence is that biology and technology, the two cornerstones of biotechnology, aren't as incompatible as they first appear.

The concept of bioconvergence is not restricted to specific biotech chain phases. It's a method that can be used from beginning to end. The bioconvergence paradigm is at the foundation of many new fields in biotech, including omics, biomimicry, bioprinting, and diagnostics.

Researchers must produce outstanding advancements in medical research and therapy due to the rising prevalence of chronic diseases afflicting the global population. The race to have a significant influence is on. New cancer therapies, better medications and vaccinations, quick testing and precise diagnosis, better and simpler access to healthcare services via digital means, and so forth.

COVID-19 Impact Analysis

The COVID-19 pandemic had a significant influence on medical technology, drug development, and health technology. As a result of reducing the time needed to bring a drug to market by accelerating the discovery of the sequence, virtual selection, and process of validation, AI-based tools enable the prediction of drugs or peptide bonds straight from the genomic sequences of an infectious person. This results in the boost of drugs or vaccine development and advanced technologies. AI and ML technologies have helped in screening, prediction, forecasting, contact tracing, and drug/vaccine development during the ongoing COVID pandemic. The extensive use of COVID-19 has benefited the healthcare biotechnology business as a result of these aspects.

Market Growth Factors

Industry 4.0 has created a new paradigm for the industrial sector.

Similarly to manufacturing, the delivery of healthcare is about to undergo a fundamental shift into a new era of connected, smart healthcare. Industry 4.0 and the fourth healthcare revolution are currently emerging. In such a situation, the process of providing healthcare transforms into a cyber-physical system outfitted with wearables, RFID (radio-frequency identification), IoT, and various medical devices, medical robots, intelligent sensors, etc., that are incorporated with cloud computing, artificial intelligence, big data analysis, and decision support methods for achieving smart and interconnected healthcare delivery. Therefore, as a result of industry 4.0's widespread acceptance in the healthcare sector.

Bioconvergence As A Source Of Finance For New Businesses

Every industry has specific financial needs and worries, whether they relate to accessibility, available channels, investor kinds, or investment size. The locations of such start-ups are frequently based on the availability of funding. For medical and life science start-ups, access to funding for research (long-term ROI on higher-than-average investments) is a major challenge.

Market Restraining Factors

Rising Data Privacy Concerns Because Of Ai Implementation In Healthcare

There are several practical uses for AI in the medical field. However, due to worries about data protection, AI use in the sector is constrained. In several nations, patient health data is protected by federal regulations, and any violations or failures to maintain its integrity may result in monetary and legal consequences. Since patient care utilizing AI necessitates access to numerous health datasets, AI-based technologies must follow all data security regulations put in place by regulatory and governmental bodies. The market for healthcare bioconvergence is severely constrained by this problem.

Application Outlook

Based on applications, the market is classified into drug discovery, nano-robotics for drug delivery, regenerative medicine, diagnostic & biological sensor, bioelectronics, engineered living materials, optogenetics, precision medicine, and standalone. A new strategy called precision medicine (PM) gives the idea that it will alter the way that medicine is now practiced. Modern healthcare is being transformed by the IoT movement, which offers promising technological, economic, and societal prospects. The IoT, whose usage in PM is increasing, can be integrated to further strengthen the function that PM performs. Such increasing utilization of IoT in PM will aid in the growth of the bioconvergence market in healthcare.

Healthcare Bioconvergence Market Share and Industry Analysis Report 2021

Healthcare Bioconvergence Market Report Coverage
Report Attribute Details
Market size value in 2021 USD 107.1 Billion
Market size forecast in 2028 USD 169.9 Billion
Base Year 2021
Historical Period 2018 to 2020
Forecast Period 2022 to 2028
Revenue Growth Rate CAGR of 7% from 2022 to 2028
Number of Pages 142
Number of Tables 217
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered Application, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Industry 4.0 has created a new paradigm for the industrial sector.
  • Bioconvergence As A Source Of Finance For New Businesses
Restraints
  • Rising Data Privacy Concerns Because Of Ai Implementation In Healthcare

Regional Outlook

Based on geography, the market is classified in North America, Europe, Asia Pacific, and LAMEA. In 2021, the Europe market gained the largest revenue share in the healthcare bioconvergence market as the region is home to prestigious research institutions, medical facilities, and hospitals that provide a solid foundation for identifying and developing cutting-edge scientific and medical therapies. The market is primarily driven by the highly developed healthcare sector and the prevalence of cutting-edge healthcare infrastructure in nations including the U.K., France, and Germany, among others.

Free Valuable Insights: Global Healthcare Bioconvergence Market size to reach USD 169.9 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BiomX, Inc., Singota Solutions, Anima Biotech Inc., Ginkgo Bioworks Holdings, Inc., SetPoint Medical Corporation, Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), and BICO Group AB (publ)

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Drug Discovery
  • Precision Medicine
  • Regenerative Medicine
  • Diagnostic & Biological Sensors
  • Bioelectronics
  • Nanorobotics for Drug Delivery
  • Engineered Living Materials
  • Optogenetics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • BiomX, Inc.
  • Singota Solutions
  • Anima Biotech Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • SetPoint Medical Corporation
  • Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
  • BICO Group AB (publ)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Healthcare Bioconvergence Market, by Application
1.4.2 Global Healthcare Bioconvergence Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Healthcare Bioconvergence Market by Application
3.1 Global Drug Discovery Market by Region
3.2 Global Precision Medicine Market by Region
3.3 Global Regenerative Medicine Market by Region
3.4 Global Diagnostic & Biological Sensors Market by Region
3.5 Global Bioelectronics Market by Region
3.6 Global Nanorobotics for Drug Delivery Market by Region
3.7 Global Engineered Living Materials Market by Region
3.8 Global Optogenetics Market by Region

Chapter 4. Global Healthcare Bioconvergence Market by Region
4.1 North America Healthcare Bioconvergence Market
4.1.1 North America Healthcare Bioconvergence Market by Application
4.1.1.1 North America Drug Discovery Market by Country
4.1.1.2 North America Precision Medicine Market by Country
4.1.1.3 North America Regenerative Medicine Market by Country
4.1.1.4 North America Diagnostic & Biological Sensors Market by Country
4.1.1.5 North America Bioelectronics Market by Country
4.1.1.6 North America Nanorobotics for Drug Delivery Market by Country
4.1.1.7 North America Engineered Living Materials Market by Country
4.1.1.8 North America Optogenetics Market by Country
4.1.2 North America Healthcare Bioconvergence Market by Country
4.1.2.1 US Healthcare Bioconvergence Market
4.1.2.1.1 US Healthcare Bioconvergence Market by Application
4.1.2.2 Canada Healthcare Bioconvergence Market
4.1.2.2.1 Canada Healthcare Bioconvergence Market by Application
4.1.2.3 Mexico Healthcare Bioconvergence Market
4.1.2.3.1 Mexico Healthcare Bioconvergence Market by Application
4.1.2.4 Rest of North America Healthcare Bioconvergence Market
4.1.2.4.1 Rest of North America Healthcare Bioconvergence Market by Application
4.2 Europe Healthcare Bioconvergence Market
4.2.1 Europe Healthcare Bioconvergence Market by Application
4.2.1.1 Europe Drug Discovery Market by Country
4.2.1.2 Europe Precision Medicine Market by Country
4.2.1.3 Europe Regenerative Medicine Market by Country
4.2.1.4 Europe Diagnostic & Biological Sensors Market by Country
4.2.1.5 Europe Bioelectronics Market by Country
4.2.1.6 Europe Nanorobotics for Drug Delivery Market by Country
4.2.1.7 Europe Engineered Living Materials Market by Country
4.2.1.8 Europe Optogenetics Market by Country
4.2.2 Europe Healthcare Bioconvergence Market by Country
4.2.2.1 Germany Healthcare Bioconvergence Market
4.2.2.1.1 Germany Healthcare Bioconvergence Market by Application
4.2.2.2 UK Healthcare Bioconvergence Market
4.2.2.2.1 UK Healthcare Bioconvergence Market by Application
4.2.2.3 France Healthcare Bioconvergence Market
4.2.2.3.1 France Healthcare Bioconvergence Market by Application
4.2.2.4 Russia Healthcare Bioconvergence Market
4.2.2.4.1 Russia Healthcare Bioconvergence Market by Application
4.2.2.5 Spain Healthcare Bioconvergence Market
4.2.2.5.1 Spain Healthcare Bioconvergence Market by Application
4.2.2.6 Italy Healthcare Bioconvergence Market
4.2.2.6.1 Italy Healthcare Bioconvergence Market by Application
4.2.2.7 Rest of Europe Healthcare Bioconvergence Market
4.2.2.7.1 Rest of Europe Healthcare Bioconvergence Market by Application
4.3 Asia Pacific Healthcare Bioconvergence Market
4.3.1 Asia Pacific Healthcare Bioconvergence Market by Application
4.3.1.1 Asia Pacific Drug Discovery Market by Country
4.3.1.2 Asia Pacific Precision Medicine Market by Country
4.3.1.3 Asia Pacific Regenerative Medicine Market by Country
4.3.1.4 Asia Pacific Diagnostic & Biological Sensors Market by Country
4.3.1.5 Asia Pacific Bioelectronics Market by Country
4.3.1.6 Asia Pacific Nanorobotics for Drug Delivery Market by Country
4.3.2 Asia Pacific Engineered Living Materials Market by Country
4.3.2.1 Asia Pacific Optogenetics Market by Country
4.3.3 Asia Pacific Healthcare Bioconvergence Market by Country
4.3.3.1 China Healthcare Bioconvergence Market
4.3.3.1.1 China Healthcare Bioconvergence Market by Application
4.3.3.2 Japan Healthcare Bioconvergence Market
4.3.3.2.1 Japan Healthcare Bioconvergence Market by Application
4.3.3.3 India Healthcare Bioconvergence Market
4.3.3.3.1 India Healthcare Bioconvergence Market by Application
4.3.3.4 South Korea Healthcare Bioconvergence Market
4.3.3.4.1 South Korea Healthcare Bioconvergence Market by Application
4.3.3.5 Singapore Healthcare Bioconvergence Market
4.3.3.5.1 Singapore Healthcare Bioconvergence Market by Application
4.3.3.6 Malaysia Healthcare Bioconvergence Market
4.3.3.6.1 Malaysia Healthcare Bioconvergence Market by Application
4.3.3.7 Rest of Asia Pacific Healthcare Bioconvergence Market
4.3.3.7.1 Rest of Asia Pacific Healthcare Bioconvergence Market by Application
4.4 LAMEA Healthcare Bioconvergence Market
4.4.1 LAMEA Healthcare Bioconvergence Market by Application
4.4.1.1 LAMEA Drug Discovery Market by Country
4.4.1.2 LAMEA Precision Medicine Market by Country
4.4.1.3 LAMEA Regenerative Medicine Market by Country
4.4.1.4 LAMEA Diagnostic & Biological Sensors Market by Country
4.4.1.5 LAMEA Bioelectronics Market by Country
4.4.1.6 LAMEA Nanorobotics for Drug Delivery Market by Country
4.4.1.7 LAMEA Engineered Living Materials Market by Country
4.4.1.8 LAMEA Optogenetics Market by Country
4.4.2 LAMEA Healthcare Bioconvergence Market by Country
4.4.2.1 Brazil Healthcare Bioconvergence Market
4.4.2.1.1 Brazil Healthcare Bioconvergence Market by Application
4.4.2.2 Argentina Healthcare Bioconvergence Market
4.4.2.2.1 Argentina Healthcare Bioconvergence Market by Application
4.4.2.3 UAE Healthcare Bioconvergence Market
4.4.2.3.1 UAE Healthcare Bioconvergence Market by Application
4.4.2.4 Saudi Arabia Healthcare Bioconvergence Market
4.4.2.4.1 Saudi Arabia Healthcare Bioconvergence Market by Application
4.4.2.5 South Africa Healthcare Bioconvergence Market
4.4.2.5.1 South Africa Healthcare Bioconvergence Market by Application
4.4.2.6 Nigeria Healthcare Bioconvergence Market
4.4.2.6.1 Nigeria Healthcare Bioconvergence Market by Application
4.4.2.7 Rest of LAMEA Healthcare Bioconvergence Market
4.4.2.7.1 Rest of LAMEA Healthcare Bioconvergence Market by Application

Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview
TABLE 1 Global Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 2 Global Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 3 Global Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Drug Discovery Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Drug Discovery Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Precision Medicine Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Precision Medicine Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Regenerative Medicine Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Regenerative Medicine Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Diagnostic & Biological Sensors Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Diagnostic & Biological Sensors Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Bioelectronics Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Bioelectronics Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Nanorobotics for Drug Delivery Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Nanorobotics for Drug Delivery Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Engineered Living Materials Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Engineered Living Materials Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Optogenetics Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Optogenetics Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Healthcare Bioconvergence Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Healthcare Bioconvergence Market by Region, 2022 - 2028, USD Million
TABLE 23 North America Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 24 North America Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 25 North America Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 26 North America Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 27 North America Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 45 US Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 46 US Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 47 US Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 48 US Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 49 Canada Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 50 Canada Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 51 Canada Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 52 Canada Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 53 Mexico Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 54 Mexico Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 55 Mexico Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 56 Mexico Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of North America Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 58 Rest of North America Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 59 Rest of North America Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 60 Rest of North America Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 61 Europe Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 62 Europe Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 63 Europe Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 64 Europe Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 65 Europe Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 66 Europe Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 67 Europe Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 68 Europe Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 69 Europe Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 70 Europe Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 71 Europe Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 72 Europe Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 73 Europe Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 74 Europe Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 75 Europe Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 78 Europe Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 79 Europe Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 82 Europe Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 83 Germany Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 84 Germany Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 85 Germany Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 86 Germany Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 87 UK Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 88 UK Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 89 UK Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 90 UK Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 91 France Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 92 France Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 93 France Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 94 France Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 95 Russia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 96 Russia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 97 Russia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 98 Russia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 99 Spain Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 100 Spain Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 101 Spain Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 102 Spain Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 103 Italy Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 104 Italy Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 105 Italy Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 106 Italy Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 107 Rest of Europe Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 108 Rest of Europe Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 109 Rest of Europe Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 110 Rest of Europe Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 111 Asia Pacific Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 112 Asia Pacific Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 113 Asia Pacific Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 114 Asia Pacific Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 115 Asia Pacific Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 116 Asia Pacific Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 117 Asia Pacific Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 118 Asia Pacific Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 119 Asia Pacific Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 120 Asia Pacific Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 121 Asia Pacific Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 122 Asia Pacific Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 123 Asia Pacific Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 124 Asia Pacific Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 125 Asia Pacific Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 126 Asia Pacific Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 127 Asia Pacific Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 128 Asia Pacific Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 129 Asia Pacific Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 130 Asia Pacific Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 131 Asia Pacific Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 132 Asia Pacific Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 133 China Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 134 China Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 135 China Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 136 China Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 137 Japan Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 138 Japan Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 139 Japan Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 140 Japan Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 141 India Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 142 India Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 143 India Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 144 India Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 145 South Korea Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 146 South Korea Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 147 South Korea Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 148 South Korea Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 149 Singapore Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 150 Singapore Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 151 Singapore Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 152 Singapore Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 153 Malaysia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 154 Malaysia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 155 Malaysia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 156 Malaysia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 157 Rest of Asia Pacific Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 158 Rest of Asia Pacific Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 159 Rest of Asia Pacific Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 160 Rest of Asia Pacific Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 161 LAMEA Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 162 LAMEA Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 163 LAMEA Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 164 LAMEA Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 165 LAMEA Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 166 LAMEA Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 167 LAMEA Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 168 LAMEA Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 169 LAMEA Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 170 LAMEA Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 171 LAMEA Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 172 LAMEA Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 173 LAMEA Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 174 LAMEA Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 175 LAMEA Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 176 LAMEA Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 177 LAMEA Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 178 LAMEA Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 179 LAMEA Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 180 LAMEA Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 181 LAMEA Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 182 LAMEA Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 183 Brazil Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 184 Brazil Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 185 Brazil Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 186 Brazil Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 187 Argentina Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 188 Argentina Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 189 Argentina Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 190 Argentina Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 191 UAE Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 192 UAE Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 193 UAE Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 194 UAE Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 195 Saudi Arabia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 196 Saudi Arabia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 197 Saudi Arabia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 198 Saudi Arabia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 199 South Africa Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 200 South Africa Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 201 South Africa Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 202 South Africa Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 203 Nigeria Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 204 Nigeria Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 205 Nigeria Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 206 Nigeria Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 207 Rest of LAMEA Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 208 Rest of LAMEA Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 209 Rest of LAMEA Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 210 Rest of LAMEA Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 211 Key Information – BiomX, Inc.
TABLE 212 Key Information – Galvani Bioelectronics, Ltd.
TABLE 213 Key Information – BICO Group AB (publ)
TABLE 214 Key Information – Ginkgo Bioworks Holdings, Inc.
TABLE 215 Key Information – Singota Solutions
TABLE 216 Key Information – Anima Biotech Inc.
TABLE 217 Key Information – Setpoint Medical Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Healthcare Bioconvergence Market share by Application, 2021
FIG 3 Global Healthcare Bioconvergence Market share by Application, 2028
FIG 4 Global Healthcare Bioconvergence Market by Application, 2018 - 2028, USD Million
FIG 5 Global Healthcare Bioconvergence Market share by Region, 2021
FIG 6 Global Healthcare Bioconvergence Market share by Region, 2028
FIG 7 Global Healthcare Bioconvergence Market by Region, 2018 - 2028, USD Million
FIG 8 Recent strategies and developments: BICO Group AB (publ)

Purchase Full Report of
Healthcare Bioconvergence Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL